Key result
Incretin receptor agonists are linked to improved CPAP adherence in diabetes, obesity, and OSA.
Why the study?
To evaluate the association of incretin receptor agonists with CPAP use, mortality, and hospitalization in adults with diabetes, obesity, and obstructive sleep apnea.
Do incretin receptor agonists (IRAs) affect continuous positive airway pressure (CPAP) use, mortality, and hospitalization in adults with diabetes, obesity, and obstructive sleep apnea?
Do incretin receptor agonists (IRAs) affect continuous positive airway pressure (CPAP) use, mortality, and hospitalization in adults with diabetes, obesity, and obstructive sleep apnea?
Cohort study investigates the link between incretin receptor agonists and CPAP use in adults, suggesting health implications.
This cohort study investigates the association of incretin receptor agonists (IRAs) with continuous positive airway pressure (CPAP) use, mortality, and hospitalization among adults with diabetes, obesity, and obstructive sleep apnea.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2025) studied this question. Incretin receptor agonists were associated with improved CPAP adherence in adults with diabetes, obesity, and obstructive sleep apnea.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: